Prelude Therapeutics Incorporated

PRLD·NasdaqGS·Healthcare
Compare
4.0800+0.3000 (+7.94%)today
At close: Nov 4, 4:00 PM EST · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close3.7800
Open3.8400
Day range3.74004.1600
52-week range1.17306.8300
Off day high−1.92%
Off 52-week high−40.26%
Volume377.89K
Avg. volume (3M)491.55K
Market cap325.60M
EPS (TTM)-0.7300
Forward P/E-7.03
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)1.19
Shares outstanding65.08M
Short interest20.14% of float
Earnings dateAug 11, 2026 (est.)
Analyst target9.2000
Profit margin−269.75%

Against its peers

Compare in full ›
PRLD PYXS BBOT HURA ONCO.ST CCCC
Market cap 325.60M 198.30M 184.40M 109.61M 745.39M 383.84M
P/E (TTM) — — — — — —
Forward P/E -7.0 -1.5 -0.8 -2.8 -2.4 -3.4
Price/book 3.1 9.2 0.6 6.0 27.4 1.6
Dividend yield — — — — — —
1-year change +171.94% −58.06% −81.29% −29.80% −63.90% +35.44%
Today +7.94% +1.22% −0.86% +3.93% +0.23% −2.80%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Related companies

Compare ›

The businesses closest to Prelude Therapeutics's by what they do, from their descriptions, with the same industry weighted in.

Company Mkt cap Price Today
Pyxis Oncology, Inc.PYXS · Biotechnology 198.30M 1.6600 +1.22%
BridgeBio Oncology Therapeutics, Inc.BBOT · Biotechnology 184.40M 2.3000 −0.86%
TuHURA Biosciences, Inc.HURA · Biotechnology 109.61M 1.7200 +3.93%
Oncopeptides AB (publ)ONCO.ST · Biotechnology 745.39M 1.7280 +0.23%
C4 Therapeutics, Inc.CCCC · Biotechnology 383.84M 3.1200 −2.80%
Monte Rosa Therapeutics, Inc.GLUE · Biotechnology 923.09M 10.82 +3.94%
MacroGenics, Inc.MGNX · Biotechnology 147.15M 2.3100 −0.86%
Faeth Therapeutics, Inc.FTH · Biotechnology 516.62M 19.99 +1.73%

Other companies in Biotechnology, closest in size first.

Company Mkt cap Price Today
ARS Pharmaceuticals, Inc.SPRY · San Diego, CA 303.31M 3.0500 0.00%
Enanta Pharmaceuticals, Inc.ENTA · Watertown, MA 310.19M 10.65 +2.70%
Vogenx, Inc.VOGX · Raleigh, NC 293.09M 19.73 −3.90%
Agenus Inc.AGEN · Lexington, MA 314.78M 6.97 +4.50%
Eikon Therapeutics, Inc.EIKN · Millbrae, CA 346.11M 6.39 +15.14%
Scribe Therapeutics Inc.SCTX · Alameda, CA 317.67M 16.78 +3.58%
Nautilus Biotechnology, Inc.NAUT · Seattle, WA 291.68M 2.2900 −2.55%
Intervacc AB (publ)IVACC.ST · Hägersten, Sweden 290.37M 0.8520 −0.93%

Healthcare companies of a similar market value (301.66M).

Company Mkt cap Price Today
ARS Pharmaceuticals, Inc.SPRY · Biotechnology 303.31M 3.0500 0.00%
NIOX Group Plc82C.F · Medical Devices 303.93M 0.7500 +2.04%
Spectral Medical Inc.EDT.TO · Diagnostics & Research 290.62M 0.9900 +4.21%
Enanta Pharmaceuticals, Inc.ENTA · Biotechnology 310.19M 10.65 +2.70%
Vogenx, Inc.VOGX · Biotechnology 293.09M 19.73 −3.90%
Agenus Inc.AGEN · Biotechnology 314.78M 6.97 +4.50%
Broncus Holding Corporation2216.HK · Medical Devices 297.80M 0.565 −0.88%
Eikon Therapeutics, Inc.EIKN · Biotechnology 346.11M 6.39 +15.14%

Also based in Wilmington, Delaware, then elsewhere in Delaware.

Company Mkt cap Price Today
DuPont de Nemours, Inc.DD · Wilmington, DE 19.99B 150.73 −1.78%
Marvell Technology, Inc.MRVL · Wilmington, DE 143.78B 159.80 −7.08%
Qnity Electronics, Inc.Q · Wilmington, DE 24.85B 118.78 −0.09%
Incyte CorporationINCY · Wilmington, DE 25.04B 122.85 +4.47%
InterDigital, Inc.IDCC · Wilmington, DE 7.94B 308.50 −1.63%
WSFS Financial CorporationWSFS · Wilmington, DE 4.17B 81.08 +1.48%
Ashland Inc.ASH · Wilmington, DE 3.50B 76.44 +4.68%
Clover Health Investments, Corp.CLOV · Wilmington, DE 2.49B 4.6900 +9.32%

From the 4SEARCH.business instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 20 min.

Latest news

All PRLD news ›
markets.businessinsider.com··2 outletsPositive

Prelude Therapeutics to Participate in the Chardan Healthcare Conference

WILMINGTON, Del., Oct. 16, 2026 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (Prelude) (Nasdaq: PRLD), a clinical-stage precision oncol... Prelude Therapeutics to Participate in the Chardan Healthcare Conference WILMINGTON, Del.,…

PRLDINCY
More from 1 other outlet
Stocktwits··2 outlets

Prelude Therapeutics Teams Up With Lilly To Test Experimental Breast Cancer Drug In Phase 1 Trial

Prelude Therapeutics (PRLD) announced a clinical trial collaboration and supply agreement with Eli Lilly and Company (LLY) on Tuesday to evaluate its experimental breast cancer drug PRT13722 in combination with two Lilly medicines. At the…

PFEPRLDAZNLLY
More from 1 other outlet

From the 4Search news index, newest first.

In the news

16mentions in 30 days
14with it in the headline
Positivesentiment

Mentioned with

Incyte15American Association for Cancer Research14European Hematology Association 2025 Congress14American Society of Hematology13Eli Lilly10Chardan Healthcare Conference8U.S. Food and Drug Administration8LinkedIn7

People in the coverage

Charles Morris16Robert A. Doody16Bryant Lim10Kris Vaddi10Peggy Scherle10Andrew Combs7

Themes

Healthcare12Events7SEC Filings7Therapeutics7Conference6Oncology5Participate5Cancer4

Most coverage from

  1. markets.businessinsider.com4
  2. themarketsdaily.com2
  3. defenseworld.net1
  4. globenewswire.com1
  5. manilatimes.net1

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 16 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance